| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Surgical Wound Infection | 9 | 2019 | 501 | 2.17 | Why? |
| Urinary Tract Infections | 5 | 2019 | 534 | 1.57 | Why? |
| Switzerland | 28 | 2021 | 2738 | 1.54 | Why? |
| Transurethral Resection of Prostate | 2 | 2019 | 20 | 1.52 | Why? |
| Prostatic Hyperplasia | 2 | 2019 | 161 | 1.36 | Why? |
| Laser Therapy | 2 | 2019 | 158 | 1.29 | Why? |
| Hospital Costs | 2 | 2018 | 274 | 1.14 | Why? |
| Bacteremia | 6 | 2019 | 1372 | 1.07 | Why? |
| Mycobacterium Infections | 3 | 2018 | 72 | 1.05 | Why? |
| Thoracic Surgery | 2 | 2020 | 623 | 0.92 | Why? |
| Antibiotic Prophylaxis | 3 | 2019 | 399 | 0.91 | Why? |
| Trimethoprim, Sulfamethoxazole Drug Combination | 2 | 2019 | 170 | 0.88 | Why? |
| Cross Infection | 10 | 2019 | 8675 | 0.82 | Why? |
| Enterocolitis, Pseudomembranous | 2 | 2017 | 93 | 0.79 | Why? |
| Anti-Infective Agents, Urinary | 1 | 2019 | 27 | 0.78 | Why? |
| Air Microbiology | 3 | 2020 | 1322 | 0.76 | Why? |
| Prospective Payment System | 1 | 2018 | 28 | 0.74 | Why? |
| Antisepsis | 1 | 2017 | 30 | 0.70 | Why? |
| Gram-Positive Bacterial Infections | 3 | 2019 | 323 | 0.67 | Why? |
| Urology Department, Hospital | 1 | 2018 | 150 | 0.67 | Why? |
| Cardiac Surgical Procedures | 6 | 2020 | 1931 | 0.67 | Why? |
| Anti-Bacterial Agents | 12 | 2019 | 10083 | 0.67 | Why? |
| Staphylococcal Infections | 4 | 2017 | 1099 | 0.64 | Why? |
| Equipment Failure | 1 | 2018 | 197 | 0.62 | Why? |
| Epidemiologic Studies | 1 | 2018 | 554 | 0.62 | Why? |
| Water Microbiology | 1 | 2018 | 248 | 0.61 | Why? |
| Escherichia coli Infections | 2 | 2018 | 348 | 0.60 | Why? |
| Insurance Coverage | 1 | 2019 | 348 | 0.57 | Why? |
| Escherichia coli | 3 | 2018 | 1547 | 0.55 | Why? |
| Prostatectomy | 1 | 2019 | 485 | 0.55 | Why? |
| Operating Rooms | 3 | 2020 | 1841 | 0.53 | Why? |
| Scabies | 2 | 2019 | 75 | 0.53 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 2 | 2017 | 711 | 0.53 | Why? |
| Pseudomonas Infections | 1 | 2018 | 425 | 0.52 | Why? |
| Insurance, Health | 1 | 2019 | 634 | 0.51 | Why? |
| Respiratory Syncytial Viruses | 1 | 2017 | 612 | 0.51 | Why? |
| Enterococcus faecalis | 1 | 2013 | 126 | 0.50 | Why? |
| Enterococcus faecium | 1 | 2013 | 95 | 0.49 | Why? |
| Gastrointestinal Hemorrhage | 1 | 2019 | 669 | 0.48 | Why? |
| Coronary Artery Bypass | 1 | 2018 | 629 | 0.46 | Why? |
| Mycobacterium | 3 | 2018 | 143 | 0.46 | Why? |
| Digestive System Surgical Procedures | 1 | 2018 | 677 | 0.44 | Why? |
| Methicillin Resistance | 2 | 2008 | 77 | 0.41 | Why? |
| Sarcoptes scabiei | 1 | 2009 | 4 | 0.41 | Why? |
| Catheters, Indwelling | 3 | 2018 | 84 | 0.39 | Why? |
| Cefuroxime | 2 | 2019 | 17 | 0.38 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.37 | Why? |
| Guideline Adherence | 3 | 2018 | 2309 | 0.37 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2017 | 1234 | 0.35 | Why? |
| Hand Disinfection | 1 | 2018 | 1671 | 0.34 | Why? |
| Disinfectants | 1 | 2018 | 1077 | 0.34 | Why? |
| Anti-Infective Agents | 2 | 2018 | 1766 | 0.32 | Why? |
| Polymerase Chain Reaction | 3 | 2017 | 6740 | 0.31 | Why? |
| Prostatic Neoplasms | 1 | 2019 | 1637 | 0.31 | Why? |
| Infection Control | 5 | 2020 | 23131 | 0.30 | Why? |
| Premature Birth | 1 | 2017 | 2151 | 0.30 | Why? |
| Practice Patterns, Physicians' | 3 | 2018 | 4927 | 0.28 | Why? |
| Hospitals, University | 5 | 2018 | 4173 | 0.27 | Why? |
| Prospective Studies | 12 | 2020 | 43301 | 0.26 | Why? |
| Gram-Negative Bacterial Infections | 2 | 2019 | 398 | 0.26 | Why? |
| Staphylococcus aureus | 2 | 2008 | 844 | 0.25 | Why? |
| Machine Learning | 1 | 2018 | 4395 | 0.23 | Why? |
| Nose | 1 | 2008 | 1093 | 0.22 | Why? |
| Gram-Positive Bacteria | 2 | 2019 | 230 | 0.22 | Why? |
| Drug Administration Schedule | 2 | 2019 | 2324 | 0.22 | Why? |
| Ribotyping | 2 | 2017 | 54 | 0.21 | Why? |
| Postoperative Complications | 1 | 2019 | 5861 | 0.21 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 4 | 2020 | 9706 | 0.21 | Why? |
| Pharynx | 1 | 2008 | 1544 | 0.20 | Why? |
| Device Approval | 1 | 2020 | 93 | 0.20 | Why? |
| Periodicity | 1 | 2019 | 34 | 0.20 | Why? |
| Cerebral Ventricles | 1 | 2018 | 16 | 0.20 | Why? |
| Physician Incentive Plans | 1 | 2018 | 18 | 0.19 | Why? |
| Incidence | 7 | 2019 | 25622 | 0.19 | Why? |
| Aerosols | 3 | 2020 | 5393 | 0.19 | Why? |
| Aged | 27 | 2021 | 215776 | 0.19 | Why? |
| Tertiary Care Centers | 4 | 2018 | 8248 | 0.19 | Why? |
| Equivalence Trials as Topic | 1 | 2019 | 242 | 0.18 | Why? |
| Diagnosis | 1 | 2019 | 71 | 0.18 | Why? |
| Bacteriuria | 1 | 2018 | 31 | 0.18 | Why? |
| Aminoglycosides | 1 | 2018 | 94 | 0.18 | Why? |
| Amoxicillin | 1 | 2018 | 98 | 0.18 | Why? |
| Air Movements | 1 | 2018 | 68 | 0.18 | Why? |
| Humans | 52 | 2021 | 930598 | 0.18 | Why? |
| Heating | 1 | 2018 | 100 | 0.17 | Why? |
| Bandages | 1 | 2018 | 109 | 0.17 | Why? |
| Ciprofloxacin | 1 | 2018 | 130 | 0.17 | Why? |
| Gram-Negative Bacteria | 2 | 2019 | 473 | 0.17 | Why? |
| Materials Testing | 1 | 2020 | 380 | 0.17 | Why? |
| Masks | 1 | 2020 | 8528 | 0.17 | Why? |
| Eye Protective Devices | 1 | 2020 | 245 | 0.17 | Why? |
| Toilet Facilities | 1 | 2018 | 88 | 0.17 | Why? |
| Male | 32 | 2021 | 367725 | 0.17 | Why? |
| Middle Aged | 28 | 2021 | 270681 | 0.16 | Why? |
| Chlorhexidine | 1 | 2018 | 176 | 0.16 | Why? |
| Quinolones | 1 | 2018 | 167 | 0.16 | Why? |
| Fluoroquinolones | 1 | 2018 | 235 | 0.16 | Why? |
| Risk Factors | 9 | 2020 | 71621 | 0.16 | Why? |
| Prescription Drug Overuse | 1 | 2017 | 59 | 0.16 | Why? |
| Vancomycin | 1 | 2019 | 328 | 0.16 | Why? |
| Skin Diseases, Bacterial | 1 | 2017 | 105 | 0.16 | Why? |
| beta-Lactams | 1 | 2018 | 210 | 0.16 | Why? |
| Personal Protective Equipment | 2 | 2020 | 15978 | 0.16 | Why? |
| International Classification of Diseases | 1 | 2019 | 265 | 0.15 | Why? |
| Colon | 2 | 2018 | 669 | 0.15 | Why? |
| Drug Resistance, Multiple, Bacterial | 3 | 2018 | 1115 | 0.15 | Why? |
| Carrier State | 1 | 2008 | 2100 | 0.15 | Why? |
| Colistin | 1 | 2018 | 217 | 0.15 | Why? |
| Permethrin | 2 | 2019 | 11 | 0.15 | Why? |
| Air Conditioning | 1 | 2018 | 215 | 0.15 | Why? |
| Carbapenem-Resistant Enterobacteriaceae | 1 | 2018 | 214 | 0.15 | Why? |
| Silver | 1 | 2018 | 327 | 0.15 | Why? |
| Equipment and Supplies, Hospital | 1 | 2018 | 272 | 0.15 | Why? |
| Hospitals | 3 | 2019 | 11793 | 0.14 | Why? |
| Carbapenems | 1 | 2018 | 343 | 0.14 | Why? |
| Hydrogen Peroxide | 1 | 2020 | 680 | 0.14 | Why? |
| Feedback | 1 | 2017 | 317 | 0.14 | Why? |
| Female | 30 | 2021 | 380317 | 0.14 | Why? |
| beta-Lactamases | 2 | 2018 | 759 | 0.14 | Why? |
| Catheter-Related Infections | 1 | 2018 | 381 | 0.14 | Why? |
| Protective Clothing | 1 | 2018 | 468 | 0.14 | Why? |
| Ampicillin Resistance | 1 | 2013 | 7 | 0.14 | Why? |
| Neutropenia | 1 | 2018 | 388 | 0.14 | Why? |
| Inappropriate Prescribing | 1 | 2017 | 284 | 0.13 | Why? |
| Minisatellite Repeats | 1 | 2013 | 53 | 0.13 | Why? |
| Chickenpox | 1 | 2017 | 194 | 0.13 | Why? |
| Proton Pump Inhibitors | 1 | 2019 | 377 | 0.13 | Why? |
| Drug Utilization | 1 | 2019 | 619 | 0.13 | Why? |
| Vancomycin Resistance | 1 | 2013 | 55 | 0.13 | Why? |
| Multimorbidity | 1 | 2019 | 703 | 0.13 | Why? |
| Pseudomonas aeruginosa | 1 | 2018 | 652 | 0.13 | Why? |
| Prosthesis-Related Infections | 1 | 2017 | 302 | 0.13 | Why? |
| Austria | 1 | 2018 | 1259 | 0.13 | Why? |
| Endemic Diseases | 1 | 2017 | 480 | 0.13 | Why? |
| Costs and Cost Analysis | 1 | 2017 | 694 | 0.12 | Why? |
| Multilocus Sequence Typing | 1 | 2013 | 264 | 0.12 | Why? |
| Enterobacteriaceae Infections | 1 | 2018 | 529 | 0.12 | Why? |
| End Stage Liver Disease | 1 | 2017 | 418 | 0.12 | Why? |
| Equipment Contamination | 2 | 2018 | 1308 | 0.12 | Why? |
| Population Surveillance | 2 | 2021 | 4967 | 0.12 | Why? |
| Anti-Infective Agents, Local | 1 | 2018 | 520 | 0.12 | Why? |
| Microbial Sensitivity Tests | 3 | 2018 | 2886 | 0.12 | Why? |
| Multicenter Studies as Topic | 1 | 2019 | 2437 | 0.11 | Why? |
| Heart Valve Prosthesis | 1 | 2017 | 533 | 0.11 | Why? |
| Antimicrobial Stewardship | 1 | 2019 | 931 | 0.11 | Why? |
| Refugees | 2 | 2019 | 809 | 0.11 | Why? |
| Cluster Analysis | 1 | 2019 | 3001 | 0.10 | Why? |
| Intensive Care Units | 3 | 2019 | 29594 | 0.10 | Why? |
| Clostridium Infections | 1 | 2017 | 595 | 0.10 | Why? |
| Equipment Design | 1 | 2020 | 3095 | 0.09 | Why? |
| Drug Prescriptions | 1 | 2017 | 1062 | 0.09 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.09 | Why? |
| Retrospective Studies | 5 | 2019 | 105322 | 0.09 | Why? |
| Primary Health Care | 2 | 2017 | 4839 | 0.09 | Why? |
| Skin | 2 | 2018 | 2096 | 0.09 | Why? |
| Basic Reproduction Number | 1 | 2020 | 2676 | 0.09 | Why? |
| Motivation | 1 | 2018 | 1640 | 0.09 | Why? |
| Aged, 80 and over | 10 | 2021 | 88759 | 0.08 | Why? |
| Insecticides | 1 | 2009 | 178 | 0.08 | Why? |
| Hand Hygiene | 1 | 2018 | 1493 | 0.08 | Why? |
| Malaria | 1 | 2017 | 1097 | 0.08 | Why? |
| Cohort Studies | 3 | 2019 | 36005 | 0.08 | Why? |
| Rehabilitation Centers | 1 | 2009 | 252 | 0.08 | Why? |
| Communicable Diseases, Emerging | 1 | 2020 | 2523 | 0.08 | Why? |
| Prevalence | 6 | 2019 | 25773 | 0.08 | Why? |
| Environmental Monitoring | 1 | 2018 | 3143 | 0.07 | Why? |
| Adolescent | 11 | 2021 | 86841 | 0.07 | Why? |
| Child, Preschool | 8 | 2021 | 36283 | 0.07 | Why? |
| Ivermectin | 2 | 2019 | 973 | 0.07 | Why? |
| Diarrhea | 1 | 2017 | 2743 | 0.07 | Why? |
| Electronic Health Records | 1 | 2018 | 3492 | 0.07 | Why? |
| Hematologic Neoplasms | 1 | 2018 | 2105 | 0.07 | Why? |
| Respiratory Tract Infections | 3 | 2020 | 6817 | 0.07 | Why? |
| Disinfection | 1 | 2018 | 2912 | 0.07 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.07 | Why? |
| Patient Isolation | 1 | 2017 | 3182 | 0.07 | Why? |
| Disease Outbreaks | 3 | 2020 | 27595 | 0.07 | Why? |
| Feces | 1 | 2018 | 4235 | 0.07 | Why? |
| Reproducibility of Results | 2 | 2017 | 11304 | 0.07 | Why? |
| Mortality | 2 | 2020 | 7132 | 0.06 | Why? |
| Time Factors | 4 | 2019 | 31397 | 0.06 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.06 | Why? |
| Adult | 15 | 2021 | 244371 | 0.06 | Why? |
| Inpatients | 1 | 2019 | 5161 | 0.06 | Why? |
| Germany | 1 | 2018 | 9196 | 0.06 | Why? |
| Surveys and Questionnaires | 6 | 2020 | 43792 | 0.06 | Why? |
| Infant | 7 | 2020 | 30274 | 0.06 | Why? |
| Klebsiella pneumoniae | 2 | 2018 | 658 | 0.06 | Why? |
| Quality Indicators, Health Care | 2 | 2017 | 580 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.06 | Why? |
| Algorithms | 1 | 2019 | 7346 | 0.06 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.05 | Why? |
| Surgical Procedures, Operative | 1 | 2017 | 2662 | 0.05 | Why? |
| Tuberculosis | 1 | 2017 | 2895 | 0.05 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.05 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.05 | Why? |
| Health Surveys | 3 | 2019 | 2841 | 0.05 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.05 | Why? |
| Epidemics | 1 | 2020 | 6407 | 0.05 | Why? |
| Syria | 1 | 2019 | 170 | 0.05 | Why? |
| Travel | 1 | 2017 | 7220 | 0.05 | Why? |
| Electrophoresis, Gel, Pulsed-Field | 1 | 2018 | 78 | 0.05 | Why? |
| Family Characteristics | 1 | 2009 | 2551 | 0.04 | Why? |
| Hydrocephalus | 1 | 2018 | 139 | 0.04 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.04 | Why? |
| Metronidazole | 1 | 2017 | 59 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 8811 | 0.04 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.04 | Why? |
| Pneumonia | 1 | 2017 | 5652 | 0.04 | Why? |
| Tanzania | 1 | 2018 | 294 | 0.04 | Why? |
| Bronchoalveolar Lavage | 1 | 2020 | 603 | 0.04 | Why? |
| Otitis Media | 1 | 2017 | 106 | 0.04 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.04 | Why? |
| Antiparasitic Agents | 1 | 2019 | 267 | 0.04 | Why? |
| Child | 7 | 2021 | 70012 | 0.04 | Why? |
| Herniorrhaphy | 1 | 2017 | 99 | 0.04 | Why? |
| Protective Devices | 1 | 2020 | 493 | 0.04 | Why? |
| Risk Assessment | 1 | 2019 | 25439 | 0.04 | Why? |
| Pragmatic Clinical Trials as Topic | 1 | 2017 | 350 | 0.04 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.04 | Why? |
| Treatment Outcome | 2 | 2019 | 51732 | 0.04 | Why? |
| Single-Blind Method | 1 | 2018 | 1283 | 0.03 | Why? |
| Iatrogenic Disease | 1 | 2017 | 304 | 0.03 | Why? |
| Infant, Newborn | 3 | 2020 | 23105 | 0.03 | Why? |
| Enterobacteriaceae | 1 | 2018 | 395 | 0.03 | Why? |
| Hospital Mortality | 1 | 2017 | 22087 | 0.03 | Why? |
| Nepal | 1 | 2017 | 1004 | 0.03 | Why? |
| United States | 1 | 2020 | 46150 | 0.03 | Why? |
| Klebsiella Infections | 1 | 2018 | 466 | 0.03 | Why? |
| Oropharynx | 1 | 2020 | 1581 | 0.03 | Why? |
| Health Facilities | 1 | 2020 | 1230 | 0.03 | Why? |
| Arthroplasty, Replacement, Knee | 1 | 2017 | 363 | 0.03 | Why? |
| Cross-Sectional Studies | 4 | 2020 | 53120 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Cost-Benefit Analysis | 1 | 2021 | 2259 | 0.03 | Why? |
| Health Services Research | 1 | 2017 | 756 | 0.03 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.02 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.02 | Why? |
| Drug Combinations | 1 | 2019 | 3852 | 0.02 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.02 | Why? |
| Health Personnel | 3 | 2020 | 29646 | 0.02 | Why? |
| Nucleocapsid Proteins | 1 | 2020 | 3120 | 0.02 | Why? |
| Viral Envelope Proteins | 1 | 2020 | 3539 | 0.02 | Why? |
| Patient Readmission | 1 | 2017 | 1543 | 0.02 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.02 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.02 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.02 | Why? |
| Cesarean Section | 1 | 2017 | 2089 | 0.02 | Why? |
| Wounds and Injuries | 1 | 2018 | 1708 | 0.02 | Why? |
| Animals | 2 | 2019 | 78931 | 0.02 | Why? |
| Epidemiological Monitoring | 1 | 2018 | 3493 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2018 | 3129 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.02 | Why? |
| Global Health | 2 | 2018 | 13911 | 0.02 | Why? |
| Outpatients | 1 | 2017 | 3417 | 0.02 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.01 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.01 | Why? |
| Patient Discharge | 1 | 2017 | 5696 | 0.01 | Why? |
| Mass Screening | 1 | 2021 | 8005 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| India | 1 | 2017 | 11875 | 0.01 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.01 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.01 | Why? |
| Genome, Viral | 1 | 2020 | 13157 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.01 | Why? |